Detalles de la búsqueda
1.
Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients.
Mult Scler
; 30(3): 336-344, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38247138
2.
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina.
Neurol Sci
; 45(2): 379-389, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38159147
3.
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.
Mult Scler
; 29(10): 1240-1249, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37491849
4.
Neuromyelitis optica spectrum disorders with and without associated autoimmune diseases.
Neurol Sci
; 44(5): 1731-1737, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645533
5.
Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis.
Neurol Sci
; 44(2): 667-676, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36319902
6.
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina.
Neurol Sci
; 44(1): 281-286, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36166174
7.
Chiasmatic lesions on conventional magnetic resonance imaging during the first event of optic neuritis in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease in a Latin American cohort.
Eur J Neurol
; 29(3): 802-809, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34799965
8.
Influenza vaccination status in multiple sclerosis patients from Latin America.
J Neurovirol
; 27(5): 750-754, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34586604
9.
Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis: Multicenter study in Argentina.
Mult Scler
; 27(4): 579-584, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32484381
10.
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Neurol Sci
; 41(11): 3329-3335, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32840711
11.
Correction to: Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Neurol Sci
; 41(11): 3369-3371, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32918634
12.
Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM).
Neurol Sci
; 41(6): 1513-1519, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31960250
13.
Correction to: Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis.
Neurol Sci
; 44(3): 1135, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36348171
14.
Correction to: Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Neurol Sci
; 42(12): 5441, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34557969
15.
An asymptomatic new lesion on MRI is a relapse and should be treated accordingly - Yes.
Mult Scler
; 25(14): 1842-1843, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31674868
16.
Burden of treatment and quality of life in relapsing remitting multiple sclerosis patients under early high efficacy therapy in Argentina: Data from the Argentinean registry.
Mult Scler Relat Disord
; 85: 105543, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520948
17.
Clinical characterization of long-term multiple sclerosis (COLuMbus) patients in Argentina: A cross-sectional non-interventional study.
Mult Scler Relat Disord
; 83: 105421, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38244525
18.
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina.
Clin Neuropharmacol
; 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38776535
19.
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings.
J Neurol
; 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38630312
20.
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
J Neurol Sci
; 461: 123052, 2024 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38797140